CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea...
South Korea's Daewoong Pharmaceutical has submitted the New Drug Application (NDA) for a new drug Fexuclue 40 mg Film-co...
The state of Victoria (Australia) and Korea have signed a Memorandum of Understanding (MoU) to collaborate on mRNA vacci...
Arum Therapeutics, a leading pharmaceutical company that specializes in the discovery of new molecules and molecule comb...
Scientists at Myongji University in South Korea have reported a device that uses tiny worms to detect lung cancer cells....
Researchers from the Korea Advanced Institute of Science and Technology (KAIST) have developed a mind-reading system for...
Lunit, a South Korea-based startup has announced the publication of its study in the Journal of Clinical Oncology (JCO)....
Seegene Inc. , South Korea's leading molecular diagnostics company, announced the appointment of Dr. Glen Hans...
A team of scientists at the Pohang University of Science and Technology (POSTECH) in South Korea has developed a wearabl...
RedHill Biopharma has entered into an exclusive license agreement with Kukbo Co., a South Korean corporation, for o...
DEKRA has signed the Memorandum of Understanding (MoU) with Korea Testing Laboratory (KTL) to develop cooperation opport...
NuclixBio Inc., a South Korean biotech company that focuses on research and development of mRNA therapeutics, has signed...
PerkinElmer has made a number of acquisitions in life sciences and diagnostics as well as R&D investments with accel...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...
A research team at South Korea-based Pohang University of Science and Technology (POSTECH), in collaboration with Dr San...
Medical Korea 2022 will be held on March 10 and 11 at the Korea International Exhibition and Convention Center (Coe...
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...
South Korea-based startup Aston Sci. has announced the completion of the Series C funding at a scale of $22.7 milli...
